Navigation Links
Active Biotech presents new pre-clinical data for the 57-57 project,at the 8th World Congress on Inflammation

LUND, Sweden, June 18, 2007-Active Biotech (OMX Nordic: ACTI) has presented pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation (www.inflammation2007.dk) held in Copenhagen June 16-20*.

"The results strengthen the further clinical development of 57-57 for the treatment of SLE and show the possibility to reduce the use of steroids. Phase II clinical trials are planned to be initiated before year end", commented Sven Andréasson, President & CEO Active Biotech.

The new pre-clinical data presented show that 57-57, in an experimental model of the disease systemic lupus erythematosus (SLE), can replace prednisolone, an anti-inflammatory corticosteroid widely used in a broad range of different inflammatory diseases, among them SLE.

Several symptoms commonly associated with SLE, such as hematuria (blood in the urine) and glomerulonephritis (inflammation in the kidneys) could be significantly reduced when combining 57-57 and a lower dose of steroid.

Lund, June 18, 2007

Active Biotech AB (Publ)

Sven Andréasson President & CEO

About SLE and 57-57 Systematic Lupus Erythematosus (SLE) is a disease of the connective tissues that can cause inflammation and damage to the connective tissue in many different organs. The disease, which progresses in "flare-ups" interspersed with relatively symptom-free periods, primarily affects women of child-bearing age. Progress and symptoms of the disease vary widely, depending on the organs affected. Without treatment, SLE can be life-threatening. Active Biotech has decided to estimate the market conservatively at 1,000,000 patients in the US and Europe. The market potential for the SLE indication is estimated at approximately USD 6 billion.

The clinical program for the 57-57 project with the main indication SLE is proceedi
'"/>




Page: 1 2

Related medicine technology :

1. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
2. Gentiums Defibrotide Seen as Active in Multiple Myeloma
3. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
4. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
5. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
6. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
7. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
8. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
9. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
10. Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
11. ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
Post Your Comments:
(Date:11/28/2014)... , Nov. 28, 2014 Aratana Therapeutics, ... focused on the licensing or acquisition, development and commercialization ... companion animals, today announced that it will present at ... to be held December 2-3, 2014, at the New ... . Steven St. Peter , M.D., ...
(Date:11/28/2014)... 2014 Chinese magnesium alloy maker DongGuan Eontec ... magnesium alloy bone fixation screw has received Chinese regulatory ... and instrument and that the company acknowledges receipt of ... Science and Technology Daily journalists Wang Xiangming ... and founder, Professor Li Yangde , has been ...
(Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Hovione Files its First Investigational New Drug Application With the FDA 2
... in a row, A dvertising ... www.eveo.com ) as the #1 Independent Digital Healthcare Agency in the ... d A ge rankings, ... (Photo:   http://photos.prnewswire.com/prnh/20110516/SF03150 ) (Logo:   http://photos.prnewswire.com/prnh/20100630/SF29260LOGO-a ...
... enhanced the capability of its GlideScope® Cobalt AVL video ... designed for small children.  The new Stat is a ... patents weighing from 10 to 28 kilograms, extending the ... kilograms) through patients weighing up to 28 kilograms. ...
Cached Medicine Technology:Eveo Ranked #1 Independent Digital Healthcare Agency in U.S. 2nd Year in a Row 2Verathon Extends Range of GlideScope Video Laryngoscope With New Single Use - GVL 2.5 Stat for Small Children 2
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
(Date:11/28/2014)... 28, 2014 Miami's Plastic Surgery of ... Practice founder Dr. Jeffrey Epstein is excited ... a groundbreaking WordPress platform, the site is uniquely designed ... Currently, up to 75% of all prospective rhinoplasty patients ... people are logging on with smartphones, tablets, and laptops, ...
(Date:11/28/2014)... 2014 Secura Consultants, based in ... marketing organizations in the country focused on delivering ... marketplace. Secura Consultants is proud to offer complimentary ... Group, a leading global financial company. , Many ... the ownership interest comes the need for business ...
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this ... as gastroesophageal reflux disease (GERD) -- a few steps may ... nose and throat specialist at Lenox Hill Hospital in New ... on Thanksgiving: Pace yourself. Rather than ... throughout the day. It,s also a good idea to have ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 ... prediabetes testing and treatment, helped employees learn their ... on-site diabetes blood screening at a local school ... Diabetes @ Work initiative. , As the ... Work program , PreDiabetes Centers is co-hosting diabetes-prevention ...
Breaking Medicine News(10 mins):Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... MECHANICSBURG, Pa., Nov. 12 Select Medical Corporation,("Select") ... Inc. ("CORA"),have mutually agreed to terminate the Agreement ... on October 1, 2007, pursuant to which Select ... Medical Corporation is a leading operator of specialty ...
... biologists at Jeffersons Kimmel Cancer Center in Philadelphia ... some potentially dangerous autoinflammatory diseases. In doing so, ... of the disease process, but have also identified ... arthritis to cancer. , Reporting in the journal ...
... 13, 8:00 EST -, SOUTH SAN FRANCISCO, ... a biopharmaceutical company, and Raven,biotechnologies, inc., a privately ... therapeutics (MAbs) for treating cancer, announced,today that their ... merger agreement. The merger is expected to create ...
... 12 Northwestern University,announced today that it ... study for women with locally recurrent or ... the efficacy of Nexavar(R),(sorafenib) tablets in combination ... cancer. Nexavar, an oral multi kinase inhibitor ...
... Letters to HHS Office of Inspector General and,Congressman ... Today, the American,Association for Homecare vigorously disputed the ... a basis for setting reimbursement rates for,power wheelchairs ... The Association outlined its concerns in letters sent ...
... found , MONDAY, Nov. 12 (HealthDay News) -- Correcting ... of life, it may lower risks for depression, U.S. ... Alabama at Birmingham studied 78 nursing home residents, 55 ... an eye exam and 64 residents who received eyeglasses ...
Cached Medicine News:Health News:Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 3Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 4Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 5Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 6Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 2Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 3Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 2Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 3Health News: Eyeglasses Upgrade Helps Elderly Battle Depression 2
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: